Gross Margin - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Gross Margin
Corcept Therapeutics Inc

98.5%
Current
99%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
98.5%
=
Gross Profit
561.1m
/
Revenue
569.6m

Gross Margin Across Competitors

Country US
Market Cap 4.6B USD
Gross Margin
99%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 834.3B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.5T DKK
Gross Margin
85%
Country US
Market Cap 388.5B USD
Gross Margin
69%
Country US
Market Cap 288.3B USD
Gross Margin
76%
Country CH
Market Cap 217B CHF
Gross Margin
73%
Country UK
Market Cap 240.7B USD
Gross Margin
82%
Country CH
Market Cap 191.6B CHF
Gross Margin
75%
Country US
Market Cap 164.9B USD
Gross Margin
71%

Profitability Report

View the profitability report to see the full profitability analysis for Corcept Therapeutics Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
98.5%
=
Gross Profit
561.1m
/
Revenue
569.6m
What is the Gross Margin of Corcept Therapeutics Inc?

Based on Corcept Therapeutics Inc's most recent financial statements, the company has Gross Margin of 98.5%.